Biologics: Targets and Therapy : Impact Factor & More
eISSN: 1177-5491pISSN: 1177-5475
Open AccessShare this on:
Key Metrics
CiteScore 
5.7
SJR
Q2Oncology
SNIP
1.05
Recommended pre-submission checks
Powered by 
Run standard language and technical checks to improve your manuscript – before you submit
Technical Compliance
Ensure manuscript complies with standard submission guidelines.
Language Quality
Improve clarity, grammar, and academic writing style.
A comprehensive report covering all these checks awaits you.
Biologics: Targets and Therapy Journal Specifications
| Overview | |
| Publisher | DOVE MEDICAL PRESS LTD |
| Language | English |
| Frequency | Continuous publication |
| Article Processing Charges | USD 2390 |
| Publication Time | 16 |
| Editorial Review Process | Anonymous peer review |
| General Details | |
| Language | English |
| Frequency | Continuous publication |
| Publication Start Year | 2007 |
| Publisher URL | Visit website |
| Website URL | Visit website |
| Publication Details | |
| Editorial Review Detail | |
| Information for authors | |
| Author instructions | Visit website |
| Copyright Details | Visit website |
| Deposit Policy | Sherpa/Romeo |
| License type | CC BY, CC BY-NC |
| OA statement | Visit website |
View less
Planning to publish in Biologics: Targets and Therapy ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in Biologics: Targets and Therapy
Enhancement of Gastric Mucosal Defense by Phytomedicine in the Context of H. pylori-Associated Ulcer Disease.
- 1 Apr 2026
- Biologics : targets & therapy
Rheumatoid Factor Beyond Rheumatoid Arthritis: A Potential Marker of Cardiometabolic and Hepatic Risk.
- 1 Apr 2026
- Biologics : targets & therapy
Anifrolumab in Refractory Oral Manifestations in Systemic Lupus Erythematosus: A Case Report and Literature Review
- 16 Mar 2026
- Biologics : Targets & Therapy
Late-Onset Ocular Myasthenia Gravis–Like Symptoms During Erenumab Therapy for Chronic Migraine: A Case Report
- 4 Mar 2026
- Biologics : Targets & Therapy
First-Line Serplulimab versus Other Anti-PD-1/PD-L1 Antibodies Plus Chemotherapy for Esophageal Squamous Cell Carcinoma: A Systematic Review with Benefit-Risk Assessment via Matching-Adjusted Indirect Comparison
- 1 Feb 2026
- Biologics: Targets and Therapy
Network Pharmacology-Based Exploration: Non-Targeted Metabolites of Lactobacillus-Fermented Chaenomeles speciosa (Sweet) Nakai, Smilax glabra Roxb. and Pueraria montana var. Lobata in Uric Acid Metabolism Intervention.
- 1 Feb 2026
- Biologics : targets & therapy
Enhancement of Gastric Mucosal Defense by Phytomedicine in the Context of H. pylori-Associated Ulcer Disease.
- 1 Apr 2026
- Biologics : targets & therapy
Rheumatoid Factor Beyond Rheumatoid Arthritis: A Potential Marker of Cardiometabolic and Hepatic Risk.
- 1 Apr 2026
- Biologics : targets & therapy
Anifrolumab in Refractory Oral Manifestations in Systemic Lupus Erythematosus: A Case Report and Literature Review
- 16 Mar 2026
- Biologics : Targets & Therapy
Late-Onset Ocular Myasthenia Gravis–Like Symptoms During Erenumab Therapy for Chronic Migraine: A Case Report
- 4 Mar 2026
- Biologics : Targets & Therapy
First-Line Serplulimab versus Other Anti-PD-1/PD-L1 Antibodies Plus Chemotherapy for Esophageal Squamous Cell Carcinoma: A Systematic Review with Benefit-Risk Assessment via Matching-Adjusted Indirect Comparison
- 1 Feb 2026
- Biologics: Targets and Therapy
Network Pharmacology-Based Exploration: Non-Targeted Metabolites of Lactobacillus-Fermented Chaenomeles speciosa (Sweet) Nakai, Smilax glabra Roxb. and Pueraria montana var. Lobata in Uric Acid Metabolism Intervention.
- 1 Feb 2026
- Biologics : targets & therapy
FAQs on Biologics: Targets and Therapy
How long has Biologics: Targets and Therapy been actively publishing? 
What is the publishing frequency of Biologics: Targets and Therapy?
How many articles did Biologics: Targets and Therapy publish last year?
What is the eISSN & pISSN for Biologics: Targets and Therapy?
What is Citescore for Biologics: Targets and Therapy?
What is SNIP score for Biologics: Targets and Therapy?
What is the SJR for Biologics: Targets and Therapy?
Who is the publisher of Biologics: Targets and Therapy?
Check if your manuscript is a good match for
undefined
Upload your manuscript to get recommendations of journals
that have published papers similar to your manuscript
Drag and drop your file here
We accept manuscripts in English. File format: .doc and .docx | Maximum size: 10 MB | Word count: 200-300,000 words | File length: less than 100 pages
Do not have a manuscript right now? Use an abstract or summary
Your document is 100% secure & confidential We use 256-bit encryption for total security and
ISO/IEC 27001:2013 Certified
What all does the report include
01. Degree of Match
02. Common Topics
03. Additional
Recommendations
Recommendations